Jump to main content
US EPA
United States Environmental Protection Agency
Search
Search
Main menu
Environmental Topics
Laws & Regulations
About EPA
Health & Environmental Research Online (HERO)
Contact Us
Print
Feedback
Export to File
Search:
This record has one attached file:
Add More Files
Attach File(s):
Display Name for File*:
Save
Citation
Tags
HERO ID
4850040
Reference Type
Journal Article
Title
Cellular inactivation induced by a radiopharmaceutical kit: role of stannous chloride
Author(s)
Assis, ML; Caceres, MR; De Mattos, JC; Caldeira-De-Araújo, A; Bernardo-Filho, M
Year
1998
Is Peer Reviewed?
1
Journal
Toxicology Letters
ISSN:
0378-4274
EISSN:
1879-3169
Volume
99
Issue
3
Page Numbers
199-205
Language
English
PMID
9862286
DOI
10.1016/S0378-4274(98)00221-5
URL
http://www.sciencedirect.com/science/article/pii/S0378427498002215
Exit
Abstract
Stannous chloride (SnCl2) has been used in many sectors of human activities such as food manufacturing and in nuclear medicine to produce radiopharmaceuticals labeled with technetium-99m (99mTc). Due to its importance and genotoxic potentiality, we decided to evaluate the biological effect induced by a nuclear medicine kit, which includes SnCl2, in association with glucoheptonic acid (GHA) which is employed for brain and renal scintigraphies. These studies were carried out with the Escherichia coli AB1157 strain and the deoxyribonucleic acid (DNA) plasmid pUC 9.1. The experiments, with different concentrations of SnCl2 and GHA, show an inverse relationship between both agents. When the GHA concentration was increased, the cellular inactivation induced by SnCl2 was reduced, as measured by the number of viable cells. Moreover, GHA protects the DNA molecule against the damage induced by SnCl2.
Keywords
Stannous chloride; Glucoheptonic acid; Technetium-99m; Plasmid DNA
Tags
OPPT
•
Sodium glucoheptonate
Literature Search
Human Health
PubMed (private)
Home
Learn about HERO
Using HERO
Search HERO
Projects in HERO
Risk Assessment
Transparency & Integrity